The management of quality costs analysis model

Holota, Tomáš; Hrubec, Jozef; Kotus, Martin; Holienčinová, Mária; Caposova, Eva

doi:10.5937/sjm11-9347

Cited by 18 publications

(14 citation statements)

References 10 publications

(6 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The studies by Al-Dujaili, 3 Holota et al, 24 and Johnston and Ozment 29 all show that by tracking, measuring, and analyzing the costs of quality, and increasing the prevention and appraisal costs, it is possible to reduce the failure costs as well as the overall quality costs. It is all about shifting the focus from a reactive to a proactive way of working, which implies that doing the right thing right the first time saves money.…”

Section: Discussionmentioning

confidence: 99%

“…18 The pharmaceutical industry is constantly looking for opportunities to break this trend, or at least reduce the pace of the cost increase. [19][20][21] In the context of the increasing costs for research and development in the pharmaceutical industry, there are documented benefits of tracking costs of quality and implementing a costof-quality analysis model in other industries in the literature, 3,9,10,[22][23][24][25][26] indicating that there are potential benefits to be realized also in clinical development. Costs of quality can be found throughout the product development chain, from the supply of raw material to the use of the end product.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Costs of Quality in Clinical Development

Eriksson

2019

Ther Innov Regul Sci

View full text Add to dashboard Cite

Background: The basis for this article is an individual project during a Master of Science program at Cranfield University, UK. Research and development (R&D) costs in the pharmaceutical industry have increased at a rate where costs have doubled compared to previous decades since the 1980s. In parallel, during recent years, there has been an increased focus on quality management within clinical development. Furthermore, pharma companies are talking about quality as a competitive advantage with an increased focus on quality metrics. The objective of this research was to confirm/reject the assumption that costs of quality are not being tracked within clinical development. Methods: The key component of this research consists of a survey that was sent out to approximately 15 of the top 50 global pharmaceutical companies. Results: The research showed that the praxis of tracking and analyzing costs of quality was not widespread within clinical development, although the tools are available and experience from other industries showed that there are potential benefits to be realized, including a reduction of total quality costs. Conclusions: Even though tools for analyzing costs of quality have been available since the 1950s, there is little evidence in the literature that quality costs are being tracked and analyzed in clinical development. On the contrary, there are examples that the clinical research part of the pharma industry is stuck in traditional ways of working. However, it is likely that tracking and analyzing costs of quality can help limit the increase of R&D costs.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Costs of Quality in Clinical Development

Eriksson

2019

Ther Innov Regul Sci

View full text Add to dashboard Cite

show abstract

“…To compete in the market, businesses in a developing country need to use quality cost management to implement preventive measures that reduce the costs of failures, reduce appraisal costs, assessment, and continually analyze results to further focus efforts on preventing failures [2]. Quality cost management is important for improving the efficiency and effectiveness of the quality management system and for improving the economic performance of enterprises [3]. Implementing the quality cost management is important for better understanding and control of processes, achieving costs reduction goals without reducing product quality and customer satisfaction [4].…”

Section: Introductionmentioning

confidence: 99%

Quality costs of machine-building enterprises in Ukraine: a control mechanism

Maslak

Grishko

Maslak

et al. 2020

TSSJ

View full text Add to dashboard Cite

This article deals with the mechanism of quality costs management of machine-building enterprises and the assessment of the impact of these costs on the economic performance of enterprises. The analysis of literature sources on the issue of quality costs analysis has helped to identify the need to determine the determinants of quality cost items for machine-building enterprises, especially within Ukraine. The authors select national machine-building enterprises for the research. The researchers analyze the impact of the cost of sales and other types of costs on the net income from the sale of products, which is the basis for the formation of the enterprise's profits. To identify the determining quality cost items, the researchers investigate the effect of the quality cost items on the cost of sales. The article deals with making mathematical models for the studied enterprises, as well as the algorithm for performing the analysis. The results of the study indicate the impact of the cost of sales on the net income from the sale of products of enterprises, which is the most significant factor among the studied ones. The results also indicate the significant impact of certain quality cost items on the cost of sales. The results of this study can be applied at the practical level in the analysis and management of quality costs of machine-building enterprises and other industries.

show abstract

“…Is should be remembered that the customer is not always interested in how specific production processes are going, or how the product is delivered to the place of sale, he is rather interested in the final effect expressed in the quality of product (Golebski et. al, 2019;Holota, 2016;Ulewicz, 2018). However, it is difficult to imagine the situation when the product quality could be designed without considering the forecasted, programed or planned processes that this product will be the subject throughout the entire life cycle (Sygut, 2018).…”

Section: Introductionmentioning

confidence: 99%

Quality of Coke used in Blast Furnace Process – Analysis of Selected Parameters

Kardas

Pustějovská

2019

Quality Production Improvement - QPI

View full text Add to dashboard Cite

The basic economic goal of pig iron process is to produce a finished product at the highest possible quality and at the lowest possible cost. The quality of pig iron depends on the quality of raw materials used in the process, quality of fuels and process parameters. The cost of fuel is one of the basic component of cost of pig iron production. Therefore, consumption of fuels should be minimized while maintaining its high quality. The main technological fuel of this process is blast furnace coke. Very often, cheaper alternative kinds of fuels are used in the form of finer sorts of coke or alternative fuels (e.g. coal dust). However, they can be used only in a limited amount. The aim of the paper is the assessment of the selected quality parameters of stabilized coke used in the blast furnace process and the comparison of their values with requirements.

show abstract

The management of quality costs analysis model

Cited by 18 publications

References 10 publications

Costs of Quality in Clinical Development

Costs of Quality in Clinical Development

Quality costs of machine-building enterprises in Ukraine: a control mechanism

Quality of Coke used in Blast Furnace Process – Analysis of Selected Parameters

Contact Info

Product

Resources

About